Insulin exposure during in vitro bovine oocyte maturation changes blastocyst gene expression and developmental potential. 2016

Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge

Metabolic imbalance impairs fertility, because changes in concentrations of metabolites and hormones in the blood and follicular fluid create an unfavourable environment for early embryonic development. Insulin is a key metabolic hormone known for its effects on fertility: insulin concentrations are increased during energy balance disturbances in diabetes or metabolic syndrome. Still, insulin is frequently used at supraphysiological concentrations for embryo in vitro culture with unknown consequences for the developmental potential of the offspring. In the present study we investigated the effects of insulin exposure during in vitro bovine oocyte maturation on developmental rates, embryo quality and gene expression. Supplementation of the maturation media with insulin at 10 or 0.1 µg mL-1 decreased blastocyst rates compared with an insulin-free control (19.8 ± 1.3% and 20.4 ± 1.3% vs 23.8 ± 1.3%, respectively; P < 0.05) and led to increased cell numbers (nearly 10% more cells on Day 8 compared with control; P < 0.05). Transcriptome analysis revealed significant upregulation of genes involved in lipid metabolism, nuclear factor (erythroid-derived 2)-like 2 (NRF2) stress response and cell differentiation, validated by quantitative polymerase chain reaction. To conclude, the results of the present study demonstrate that insulin exposure during in vitro oocyte maturation has a lasting effect on the embryo until the blastocyst stage, with a potential negative effect in the form of specific gene expression perturbations.

UI MeSH Term Description Entries

Related Publications

Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
May 2021, Theriogenology,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
September 2007, Theriogenology,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
March 2019, Theriogenology,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
January 2009, Reproduction, fertility, and development,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
September 1990, Journal of reproduction and fertility,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
April 2012, Reproduction (Cambridge, England),
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
January 1986, Acta veterinaria Scandinavica,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
March 2016, International journal of molecular sciences,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
January 2021, Frontiers in cell and developmental biology,
Denise Laskowski, and Ylva Sjunnesson, and Patrice Humblot, and Marc-André Sirard, and Göran Andersson, and Hans Gustafsson, and Renée Båge
May 2024, Developmental biology,
Copied contents to your clipboard!